Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

enVVeno Medical (NVNO) Shares Outstanding (2017 - 2020)

enVVeno Medical has reported Shares Outstanding over the past 4 years, most recently at $4.2 million for Q3 2020.

  • Quarterly results put Shares Outstanding at $4.2 million for Q3 2020, down 76.54% from a year ago — trailing twelve months through Sep 2020 was $4.2 million (down 76.54% YoY), and the annual figure for FY2019 was $717274.0, up 52.97%.
  • Shares Outstanding for Q3 2020 was $4.2 million at enVVeno Medical, up from $961962.0 in the prior quarter.
  • Over the last five years, Shares Outstanding for NVNO hit a ceiling of $17.9 million in Q2 2019 and a floor of $468904.0 in Q4 2018.
  • Median Shares Outstanding over the past 4 years was $6.1 million (2017), compared with a mean of $7.7 million.
  • Biggest five-year swings in Shares Outstanding: surged 130.79% in 2019 and later crashed 94.63% in 2020.
  • enVVeno Medical's Shares Outstanding stood at $6.1 million in 2017, then plummeted by 92.36% to $468904.0 in 2018, then soared by 52.97% to $717274.0 in 2019, then soared by 486.3% to $4.2 million in 2020.
  • The last three reported values for Shares Outstanding were $4.2 million (Q3 2020), $961962.0 (Q2 2020), and $769274.0 (Q1 2020) per Business Quant data.